Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
With
Institut Dr. Schauerte (IDS)
Age
35–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For participating centers (Sample 1: 30 lung specialists from Germany)
More than 10 years of experience in respiratory medicine
At least 500 subjects under supervision in hospital- or office-based setting: a) Focus on obstructive lung diseases. b) Board certification. c) Informed consent to participate in this study and to share files of consenting subjects.
For subjects (Sample 2: 250 COPD subjects from these 30 doctors from sample 1)
Written informed consent to use his/her data.
Age \>=40 years
Pack years \>10, current or former smoking
Duration of COPD: \>=1 year since COPD diagnosis record in subject files (also confirmed by spirometry)
No concurrent asthma diagnosis
At least one year of documented disease history at participating study doctors and have to be under the care of the before mentioned physician during this time because of COPD.
You may not be if
Subjects who are pregnant and breastfeeding (in the last 12 months)
Subjects currently participating in any interventional study
Subjects with severe comorbidities which would have influence on the COPD therapy
Clareo Health | Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impact on Treatment Decisions
